S1PR1 and metabolic dysfunction-associated steatohepatitis: In a recent study, researchers found that FTY720 (a broad-spectrum S1PR modulator against S1PR1/3/4/5) ameliorates non-alcoholic steatohepatitis in mice by reducing hepatic macrophage accumulation [32].